Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 30
  • Start Date: July 2022
Neurobiological and Neuro-immunological Mechanisms of Dyspnea in Amyotrophic Lateral Sclerosis
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 3
  • Start Date: October 1, 2021
Investigation on the Cortical Communication (CortiCom) System
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 140
  • Start Date: August 2021
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 60
  • Start Date: July 1, 2021
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 20
  • Start Date: April 15, 2021
Prevalence of Rest Dyspnea and Impact of Non Invasive Ventilation on Breathing Sensations in Patients With Congenital Central Hypoventilation Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 20
  • Start Date: April 1, 2021
Quantifying Fatigue of the Respiratory and Swallowing Musculature in Patients With Amyotrophic Lateral Sclerosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 16
  • Start Date: February 21, 2021
A Bridged Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TBN in Healthy Subjects
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 160
  • Start Date: February 15, 2021
New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 56
  • Start Date: February 1, 2021
A Phase I Study to Determine the Maximum Tolerated Dose (MTD) of HK-001 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers
Showing 1-12 of 221